Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jörg Blankenstein"'
Publikováno v:
Synthesis. 52:2106-2110
With a view to make conveniently labeled mass spectrometry standards available, a set of deuterated sphingomyelins were prepared by a new expedient, flexible, robust, scalable, and high-yielding synthetic scheme starting from 2-azido-3-O-benzoylsphin
Autor:
Diego A. Gianolio, Volker Derdau, Nicolas Philippe, George E. Duran, Jens Atzrodt, Dietmar Weitz, Jörg Blankenstein, Dorothée Semiond, Sandrine Mace, Branimir I. Sikic
Publikováno v:
Cancer Chemotherapy and Pharmacology. 81:1095-1103
The primary aim of this study was to determine cabazitaxel’s affinity for the ABCB1/P-glycoprotein (P-gp) transporter compared to first-generation taxanes. We determined the kinetics of drug accumulation and retention using [14C]-labeled taxanes in
Autor:
John Allen, Maria A. Ventura, Jörg Blankenstein, Jean Wagnon, Brigitte Pouzet, Claudine Serradeil-Le Gal, Danièle Raufaste, Marc Pascal, Sylvain Derick
Publikováno v:
American journal of physiology. Regulatory, integrative and comparative physiology. 293(2)
[3H]SSR-149415 is the first tritiated nonpeptide vasopressin V1breceptor (V1bR) antagonist ligand. It was used for studying rodent (mouse, rat, hamster) and human V1bR from native or recombinant origin. Moreover, a close comparison between the human
Autor:
Steven McIntyre, Andreas Pfaltz, Frederik Menges, Sebastian P. Smidt, Robert Hilgraf, Jörg Blankenstein, Bettina Wüstenberg, Marc Schönleber, Nicole Zimmermann, Esther Hörmann
Publikováno v:
ChemInform. 34
Cationic iridium complexes with chiral P,N-ligands and tetrakis[3,5-(trifluoromethyl)phenyl]borate (BArF) as the counterion are efficient homogeneous catalysts for the enantioselective hydrogenation of olefins. The complexes are readily prepared, air
Autor:
Jörg, Blankenstein, Andreas, Pfaltz
Publikováno v:
Angewandte Chemie (International ed. in English). 40(23)
Autor:
Andreas Pfaltz, Jörg Blankenstein
Publikováno v:
Angewandte Chemie International Edition. 40:4445
Autor:
Jörg Blankenstein, Jieping Zhu
Publikováno v:
European Journal of Organic Chemistry; May2005, Vol. 2005 Issue 10, p1949-1964, 16p
Autor:
Elise F. Villard, PhD, Aurélie Thedrez, PhD, Jorg Blankenstein, PhD, Mikaël Croyal, BSc, Thi-Thu-Trang Tran, PhD, Bruno Poirier, PhD, Jean-Christophe Le Bail, PhD, Stéphane Illiano, PhD, Estelle Nobécourt, MD, PhD, Michel Krempf, MD, PhD, Dirk J. Blom, MD, PhD, A. David Marais, MD, Philip Janiak, PhD, Anthony J. Muslin, MD, PhD, Etienne Guillot, PhD, Gilles Lambert, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 1, Iss 6, Pp 419-427 (2016)
To elucidate how the proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor alirocumab modulates lipoprotein(a) [Lp(a)] plasma levels, the authors performed a series of Lp(a) uptake studies in primary human hepatocytes and dermal fibroblasts
Externí odkaz:
https://doaj.org/article/a2e8609f65714b7b9f3d883bea5a8386